2023-02-02 General

Vaccines It’s here! This preprint from India has the first data for nasal vaccines in humans that we’ve seen. It compares of the same inactivated adenovirus delivered nasally (BBV154) and intramuscularly (Covaxin), both from Bharat Biotech: Levels of antibodies and good things range from about 1.5x to almost 2x higher when delivered nasally. There were… Continue reading 2023-02-02 General

2023-01-05 General

Long COVID Even people who don’t have classic “Long COVID”, getting COVID-19 is bad for you long-term. This paper from Florida reports that people who had COVID-19 have all-cause-mortality rates in the year after their acute phase at much higher than those who did not get COVID-19. Compared to people who were not infected with… Continue reading 2023-01-05 General

week ending 2022-12-22 General

Pathology This paper from the USA says that the more physically active people were before catching COVID-19, the milder their case was. (If that sounds familiar, that’s because this paper from September from the USA said the same thing.) This paper from the USA found that five kids with MIS-C all had variants in a… Continue reading week ending 2022-12-22 General

week ending 2022-12-15 General

I have added a page with what to do if you get COVID-19 here. (Tl;dr: stay away from your loved ones, stay entertained, irrigate your sinuses with saline, take Paxlovid if you are over 65 or clinically extremely vulnerable, make sure you have good quality air (low in particulates, warm, and between 40% and 60%… Continue reading week ending 2022-12-15 General

week ending 2022-12-08 General

Treatments This paper from the UK reports promising results of a cheap liver drug against COVID-19 (at least, in human organs outside humans). This drug does so by reducing the number of ACE2 receptors. (This seems odd to me — I thought I kind of needed my ACE2 receptors!) This paper from Hong Kong found… Continue reading week ending 2022-12-08 General

week ending 2022-12-02 General

This is a day late because the province didn’t have numbers ready yesterday, so I did other things. Mitigation Measures According to this post on a Twitter web page, as of 23 November, Twitter will allow COVID-19 disinformation. This paper found that in Canada, Pakistan, and Israel, N95-class masks worked significantly better than medical masks… Continue reading week ending 2022-12-02 General